Initiator Pharma A/S (STO:INIT)

Initiator Pharma Balance Sheet

Financials in millions DKK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	10.78	13.37	24.34	39.11	34.35	13.5
Cash & Short-Term Investments	10.78	13.37	24.34	39.11	34.35	13.5
Cash Growth	-42.53%	-45.06%	-37.78%	13.88%	154.34%	78.58%
Other Receivables	2.4	2.45	5.43	7.21	4.13	2.03
Receivables	2.4	2.45	5.43	7.21	4.13	2.03
Prepaid Expenses	-	-	-	2.01	15.23	-
Other Current Assets	-	-	-	-	-	0.06
Total Current Assets	13.19	15.82	29.77	48.33	53.7	15.59
Other Intangible Assets	-	-	-	-	-	0.01
Other Long-Term Assets	0.02	0.02	0.02	0.02	-	-
Total Assets	13.2	15.84	29.79	48.35	53.7	15.6
Accounts Payable	0.87	0.37	0.41	0.8	4.8	0.67
Accrued Expenses	0.12	0.49	2.53	-	-	-
Other Current Liabilities	0.09	0.2	0.25	0.94	0.62	0.53
Total Current Liabilities	1.07	1.05	3.19	1.75	5.42	1.19
Long-Term Debt	-	-	15.44	12.58	13.29	-
Total Liabilities	1.07	1.05	18.62	14.32	18.71	1.19
Common Stock	5.9	5.9	5.51	5.5	4.6	2.91
Retained Earnings	6.23	8.89	5.65	28.53	30.4	11.5
Shareholders' Equity	12.13	14.78	11.16	34.02	34.99	14.41
Total Liabilities & Equity	13.2	15.84	29.79	48.35	53.7	15.6
Total Debt	-	-	15.44	12.58	13.29	-
Net Cash (Debt)	10.78	13.37	8.9	26.54	21.06	13.5
Net Cash Growth	-42.53%	50.25%	-66.46%	26.02%	55.92%	78.58%
Net Cash Per Share	-	0.23	0.17	0.55	0.60	0.49
Filing Date Shares Outstanding	-	56.16	52.47	52.36	43.77	27.71
Total Common Shares Outstanding	-	56.16	52.47	52.36	43.77	27.71
Working Capital	12.11	14.77	26.58	46.58	48.28	14.4
Book Value Per Share	-	0.26	0.21	0.65	0.80	0.52
Tangible Book Value	12.13	14.78	11.16	34.02	34.99	14.4
Tangible Book Value Per Share	-	0.26	0.21	0.65	0.80	0.52

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.